- SGEN has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $55.3 million.
- SGEN is up 3.4% today from today's close.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in SGEN with the Ticky from Trade-Ideas. See the FREE profile for SGEN NOW at Trade-Ideas More details on SGEN: Seattle Genetics, Inc., a biotechnology company, develops and commercializes antibody-based therapies for the treatment of cancer. Currently there are 4 analysts that rate Seattle Genetics a buy, 2 analysts rate it a sell, and 4 rate it a hold. The average volume for Seattle Genetics has been 1.2 million shares per day over the past 30 days. Seattle has a market cap of $5.4 billion and is part of the health care sector and drugs industry. The stock has a beta of 2.36 and a short float of 29.5% with 14.62 days to cover. Shares are up 36.2% year-to-date as of the close of trading on Thursday. EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.